Multimodalitic Imaging in the N-stage of Lung Cancer
Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the diagnostic efficacy and differences between 18F-FDG PET/CT
and MR STIR sequences combined with EBUS-TBNA, 18F-FDG PET/CT combined with EBUS-TBNA, and MR
STIR sequences combined with EBUS-TBNA - three types of multimodal imaging for assessing
NSCLC N-stage, in order to select the best assessment protocol to guide treatment decisions
and prognostic assessments.